82 FR 26940 - Agency Information Collection Activities: Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 82, Issue 111 (June 12, 2017)
Federal Register Volume 82, Issue 111 (June 12, 2017)
| Page Range | 26940-26941 | |
| FR Document | 2017-12046 |
[Federal Register Volume 82, Number 111 (Monday, June 12, 2017)] [Notices] [Pages 26940-26941] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-12046] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency Information Collection Activities: Proposed Collection; Comment Request; Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery AGENCY: U.S. Department of Health and Human Services. ACTION: 30-Day notice of submission of information collection approval from the Office of Management and Budget and request for comments. ----------------------------------------------------------------------- SUMMARY: As part of a Federal Government-wide effort to streamline the process to seek feedback from the public on service delivery, U.S. Department of Health and Human Services has submitted a Generic Information Collection Request (Generic ICR): ``Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery '' to OMB for approval under the Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et. seq.). DATES: Comments on the ICR must be received on or before July 12, 2017. ADDRESSES: Submit your comments to [email protected] or via facsimile to (202) 395-5806. FOR FURTHER INFORMATION CONTACT: Report Clearance Officer, [email protected] or (202) 795-7714. SUPPLEMENTARY INFORMATION: Title: Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery Abstract: The information collection activity will garner qualitative customer and stakeholder feedback in an efficient, timely manner, in accordance with the Administration's commitment to improving service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions, but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of [[Page 26941]] products or services. These collections will allow for ongoing, collaborative and actionable communications between the Agency and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance will provide useful information, but it will not yield data that can be generalized to the overall population. This type of generic clearance for qualitative information will not be used for quantitative information collections that are designed to yield reliably actionable results, such as monitoring trends over time or documenting program performance. Such data uses require more rigorous designs that address: the target population to which generalizations will be made, the sampling frame, the sample design (including stratification and clustering), the precision requirements or power calculations that justify the proposed sample size, the expected response rate, methods for assessing potential non-response bias, the protocols for data collection, and any testing procedures that were or will be undertaken prior fielding the study. Depending on the degree of influence the results are likely to have, such collections may still be eligible for submission for other generic mechanisms that are designed to yield quantitative results. The Agency received 0 comments were received in response to the 60- day notice published in the Federal Register of March 14, 2017 (79 FR 18692). Current Actions: New collection of information. Type of Review: New Collection. Affected Public: Individuals, households, professionals, public/ private sector. Average Expected Annual Number of Activities: 600. Respondents per Activity: 50. Annual Responses: 30,000. Frequency of Response: Once per request. Average Minutes per Response: 30. Burden Hours: 500,000 hours annually. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid Office of Management and Budget control number. Darius Taylor, Deputy Information Collection Officer. [FR Doc. 2017-12046 Filed 6-9-17; 8:45 am] BILLING CODE 4150-25-P
![26940 Federal Register / Vol. 82, No. 111 / Monday, June 12, 2017 / Notices
intramural and extramural scientific meeting, the background material will Dated: June 6, 2017.
research programs. This meeting is open be made publicly available at the Anna K. Abram,
to the public. location of the advisory committee Deputy Commissioner for Policy, Planning,
DATES: The meeting will be held on June meeting, and the background material Legislation, and Analysis.
26, 2017, from 9 a.m. to 2 p.m. will be posted on FDA’s Web site after [FR Doc. 2017–12036 Filed 6–9–17; 8:45 am]
ADDRESSES: FDA White Oak Campus, the meeting. Background material is BILLING CODE 4164–01–P
10903 New Hampshire Ave., Bldg. 31, available at https://www.fda.gov/
Rm. 1406, Silver Spring, MD 20993. AdvisoryCommittees/Calendar/
This meeting will take place via audio default.htm. Scroll down to the DEPARTMENT OF HEALTH AND
Webcast. To access the link for the appropriate advisory committee meeting HUMAN SERVICES
audio Webcast check the Agency’s Web link.
site at https://www.fda.gov/ Agency Information Collection
AdvisoryCommittees/default.htm and Procedure: Interested persons may Activities: Proposed Collection;
scroll down to the appropriate advisory present data, information, or views, Comment Request; Generic Clearance
committee meeting link. Answers to orally or in writing, on issues pending for the Collection of Qualitative
commonly asked questions including before the committee. Written Feedback on Agency Service Delivery
information regarding special submissions may be made to the contact AGENCY: U.S. Department of Health and
accommodations due to a disability, person on or before June 19, 2017. Oral Human Services.
visitor parking, and transportation may presentations from the public will be ACTION: 30-Day notice of submission of
be accessed at: https://www.fda.gov/ scheduled between approximately 1 information collection approval from
AdvisoryCommittees/ p.m. and 2 p.m. Those individuals the Office of Management and Budget
AboutAdvisoryCommittees/ interested in making formal oral and request for comments.
ucm408555.htm. presentations should notify the contact
For those unable to access the audio person and submit a brief statement of SUMMARY: As part of a Federal
Webcast, a conference room with a the general nature of the evidence or Government-wide effort to streamline
speakerphone will be reserved at the arguments they wish to present, the the process to seek feedback from the
meeting location provided at the names and addresses of proposed public on service delivery, U.S.
beginning of the ADDRESSES section. participants, and an indication of the Department of Health and Human
Seating is limited and is available on a Services has submitted a Generic
approximate time requested to make
first come, first served basis. Information Collection Request (Generic
their presentation on or before June 9,
FOR FURTHER INFORMATION CONTACT: ICR): ‘‘Generic Clearance for the
2017. Time allotted for each Collection of Qualitative Feedback on
Rakesh Raghuwanshi, Office of the presentation may be limited. If the
Chief Scientist, Office of the Agency Service Delivery ’’ to OMB for
number of registrants requesting to approval under the Paperwork
Commissioner, Food and Drug
speak is greater than can be reasonably Reduction Act (PRA) (44 U.S.C. 3501 et.
Administration, 10903 New Hampshire
Ave., Bldg. 1, Rm. 3309, Silver Spring accommodated during the scheduled seq.).
MD 20993, 301–796–4769, open public hearing session, FDA may DATES: Comments on the ICR must be
rakesh.raghuwanshi@fda.hhs.gov, or conduct a lottery to determine the received on or before July 12, 2017.
FDA Advisory Committee Information speakers for the scheduled open public ADDRESSES: Submit your comments to
Line, 1–800–741–8138 (301–443–0572 hearing session. The contact person will OIRA_submission@omb.eop.gov or via
in the Washington, DC area). A notice in notify interested persons regarding their facsimile to (202) 395–5806.
the Federal Register about last minute request to speak by June 12, 2017. FOR FURTHER INFORMATION CONTACT:
modifications that impact a previously Persons attending FDA’s advisory Report Clearance Officer,
announced advisory committee meeting committee meetings are advised that the Sherrette.Funn@HHS.GOV or (202) 795–
cannot always be published quickly Agency is not responsible for providing 7714.
enough to provide timely notice. access to electrical outlets. SUPPLEMENTARY INFORMATION:
Therefore, you should always check the Title: Generic Clearance for the
Agency’s Web site at https:// FDA welcomes the attendance of the
public at its advisory committee Collection of Qualitative Feedback on
www.fda.gov/AdvisoryCommittees/ Agency Service Delivery
default.htm and scroll down to the meetings and will make every effort to
Abstract: The information collection
appropriate advisory committee meeting accommodate persons with disabilities.
activity will garner qualitative customer
link, or call the advisory committee If you require accommodations due to a and stakeholder feedback in an efficient,
information line to learn about possible disability, please contact Rakesh timely manner, in accordance with the
modifications before coming to the Raghuwanshi at least 7 days in advance Administration’s commitment to
meeting. of the meeting. improving service delivery. By
SUPPLEMENTARY INFORMATION: FDA is committed to the orderly qualitative feedback we mean
Agenda: The Science Board will hear conduct of its advisory committee information that provides useful
an update on FDA’s biotechnology meetings. Please visit our Web site at insights on perceptions and opinions,
activities related to plant-derived food https://www.fda.gov/ but are not statistical surveys that yield
asabaliauskas on DSKBBXCHB2PROD with NOTICES
and animals and will hear a report from AdvisoryCommittees/ quantitative results that can be
the National Antibiotic Resistance AboutAdvisoryCommittees/ generalized to the population of study.
Monitoring System Review ucm111462.htm for procedures on This feedback will provide insights into
Subcommittee. public conduct during advisory customer or stakeholder perceptions,
FDA intends to make background committee meetings. experiences and expectations, provide
material available to the public no later an early warning of issues with service,
than 2 business days before the meeting. Notice of this meeting is given under or focus attention on areas where
If FDA is unable to post the background the Federal Advisory Committee Act (5 communication, training or changes in
material on its Web site prior to the U.S.C. app. 2). operations might improve delivery of
VerDate Sep<11>2014 17:28 Jun 09, 2017 Jkt 241001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\12JNN1.SGM 12JNN1](https://thefederalregister.org/doc/82_FR_27051/page/1.svg)
![Federal Register / Vol. 82, No. 111 / Monday, June 12, 2017 / Notices 26941
products or services. These collections DEPARTMENT OF HEALTH AND Contact Person: Amy Kathleen Wernimont,
will allow for ongoing, collaborative and HUMAN SERVICES PhD., Scientific Review Officer, Center for
actionable communications between the Scientific Review, 6701 Rockledge Drive,
Agency and its customers and National Institutes of Health Bethesda, MD 20892, 301–827–6427,
amy.wernimont@nih.gov.
stakeholders. It will also allow feedback
to contribute directly to the Center for Scientific Review; Notice of Name of Committee: Center for Scientific
improvement of program management. Closed Meetings Review Special Emphasis Panel; Immigrant
Women’s Health.
Feedback collected under this generic Pursuant to section 10(d) of the Date: June 30, 2017.
clearance will provide useful Federal Advisory Committee Act, as Time: 8:00 a.m. to 5:00 p.m.
information, but it will not yield data amended (5 U.S.C. App.), notice is Agenda: To review and evaluate grant
that can be generalized to the overall hereby given of the following meetings. applications.
population. This type of generic The meetings will be closed to the Place: The Dupont Hotel, 1500 New
clearance for qualitative information public in accordance with the Hampshire Avenue NW., Washington, DC
will not be used for quantitative provisions set forth in sections 20036.
information collections that are 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Martha L Hare, RN, PhD.,
designed to yield reliably actionable as amended. The grant applications and Scientific Review Officer, Center for
Scientific Review, National Institutes of
results, such as monitoring trends over the discussions could disclose
Health, 6701 Rockledge Drive, Room 3154,
time or documenting program confidential trade secrets or commercial MSC 7770, Bethesda, MD 20892, (301) 451–
performance. Such data uses require property such as patentable material, 8504, harem@mail.nih.gov.
more rigorous designs that address: the and personal information concerning Name of Committee: Center for Scientific
target population to which individuals associated with the grant Review Special Emphasis Panel; Member
generalizations will be made, the applications, the disclosure of which Conflict: Acute Brain Injury and
sampling frame, the sample design would constitute a clearly unwarranted Regeneration.
(including stratification and clustering), invasion of personal privacy. Date: July 3, 2017.
the precision requirements or power Name of Committee: Center for Scientific Time: 2:00 p.m. to 5:00 p.m.
calculations that justify the proposed Review Special Emphasis Panel; Member Agenda: To review and evaluate grant
sample size, the expected response rate, Conflict: Epidemiology. applications.
methods for assessing potential non- Date: June 19, 2017. Place: National Institutes of Health, 6701
response bias, the protocols for data Time: 1:00 p.m. to 4:00 p.m. Rockledge Drive, Bethesda, MD 20892
Agenda: To review and evaluate grant (Telephone Conference Call).
collection, and any testing procedures Contact Person: Alexander Yakovlev, PhD.,
that were or will be undertaken prior applications.
Place: National Institutes of Health, 6701 Scientific Review Officer, Center for
fielding the study. Depending on the Rockledge Drive, Bethesda, MD 20892 Scientific Review, National Institutes of
degree of influence the results are likely (Telephone Conference Call). Health, 6701 Rockledge Drive, Room 5206,
to have, such collections may still be Contact Person: Heidi B Friedman, PhD., MSC 7846, Bethesda, MD 20892–7846, 301–
eligible for submission for other generic Scientific Review Officer, Center for 435–1254, yakovleva@csr.nih.gov.
mechanisms that are designed to yield Scientific Review, National Institutes of (Catalogue of Federal Domestic Assistance
quantitative results. Health, 6701 Rockledge Drive, Room 1012A, Program Nos. 93.306, Comparative Medicine;
The Agency received 0 comments MSC 7770, Bethesda, MD 20892, 301–379– 93.333, Clinical Research, 93.306, 93.333,
5632, hfriedman@csr.nih.gov. 93.337, 93.393–93.396, 93.837–93.844,
were received in response to the 60-day
notice published in the Federal Register This notice is being published less than 15 93.846–93.878, 93.892, 93.893, National
days prior to the meeting due to the timing Institutes of Health, HHS)
of March 14, 2017 (79 FR 18692).
limitations imposed by the review and
Current Actions: New collection of funding cycle. Dated: June 6, 2017.
information. Name of Committee: Center for Scientific Sylvia L. Neal,
Type of Review: New Collection. Review Special Emphasis Panel; Program Analyst, Office of Federal Advisory
Affected Public: Individuals, Experimental and Bioinformatic Approaches Committee Policy.
households, professionals, public/ in the Druggable Genome. [FR Doc. 2017–12030 Filed 6–9–17; 8:45 am]
private sector. Date: June 26, 2017.
BILLING CODE 4140–01–P
Time: 10:00 a.m. to 5:00 p.m.
Average Expected Annual Number of Agenda: To review and evaluate grant
Activities: 600. applications and/or proposals.
Respondents per Activity: 50. Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND
Annual Responses: 30,000. Rockledge Drive, Bethesda, MD 20892, HUMAN SERVICES
Frequency of Response: Once per (Virtual Meeting).
Contact Person: Luis Dettin, PhD., Substance Abuse and Mental Health
request. Scientific Review Officer, Center for Services Administration
Average Minutes per Response: 30. Scientific Review, National Institutes of
Burden Hours: 500,000 hours Health, 6701 Rockledge Drive, Room 2208, Agency Information Collection
annually. Bethesda, MD 20892, 301 451 1327, Activities: Submission for OMB
An agency may not conduct or dettinle@csr.nih.gov. Review; Comment Request
sponsor, and a person is not required to Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mentored
asabaliauskas on DSKBBXCHB2PROD with NOTICES
respond to, a collection of information Periodically, the Substance Abuse and
unless it displays a currently valid Training in Comparative and Veterinary Mental Health Services Administration
Medicine. (SAMHSA) will publish a summary of
Office of Management and Budget Date: June 27, 2017.
control number. information collection requests under
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant OMB review, in compliance with the
Darius Taylor, Paperwork Reduction Act (44 U.S.C.
applications.
Deputy Information Collection Officer. Place: National Institutes of Health, 6701 Chapter 35). To request a copy of these
[FR Doc. 2017–12046 Filed 6–9–17; 8:45 am] Rockledge Drive, Bethesda, MD 20892 documents, call the SAMHSA Reports
BILLING CODE 4150–25–P (Telephone Conference Call). Clearance Officer on (240) 276–1243.
VerDate Sep<11>2014 17:28 Jun 09, 2017 Jkt 241001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\12JNN1.SGM 12JNN1](https://thefederalregister.org/doc/82_FR_27051/page/2.svg)
Document Created: 2017-06-10 01:40:50
Document Modified: 2017-06-10 01:40:50
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | 30-Day notice of submission of information collection approval from the Office of Management and Budget and request for comments. | |
| Dates | Comments on the ICR must be received on or before July 12, 2017. | |
| Contact | Report Clearance Officer, [email protected] or (202) 795-7714. | |
| FR Citation | 82 FR 26940 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR